Literature DB >> 17309969

Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.

Saburo Fukuda1, Elie Oussoultzoglou, Philippe Bachellier, Edoardo Rosso, Hiroshi Nakano, Maxime Audet, Daniel Jaeck.   

Abstract

HYPOTHESIS: The depth of portal vein (PV) wall invasion is a prognostic factor for survival after curative pancreatic resection for pancreatic ductal adenocarcinoma.
DESIGN: Retrospective clinical study.
SETTING: Department of digestive surgery and transplantation. PATIENTS: From January 1, 1990, through December 31, 2002, 121 patients underwent a curative pancreatic resection for ductal adenocarcinoma of the pancreas. Among these, 37 pancreatic resections combined with PV resection were performed. MAIN OUTCOME MEASURES: Prognostic factors for survival and predictive factors for the depth of PV wall invasion.
RESULTS: The morbidity and mortality rates did not differ between patients undergoing or not undergoing PV resection (32.4% and 2.7% [1/37], respectively, vs 38.1% and 2.4% [2/84], respectively). The 3-year survival rate after curative pancreatic resection was significantly associated with the depth of PV wall invasion. Indeed, the 3-year overall survival rate was similar for patients with no PV invasion and those with superficial invasion into the tunica adventitia (40.0% vs 32.9%, respectively; P = .85). Deeper PV wall invasion into the tunica media or the tunica intima was associated with a poorer 1-year survival rate similar to that of patients undergoing noncurative resection (21.5% vs 34.4%, respectively; P = .53). Multivariate analysis showed that the depth of PV wall invasion, number of involved lymph nodes, and volume of blood transfusion were independent factors of overall and disease-free survival. Tumor size of 45 mm or more (evaluated by computed tomography) and angiographic type C or D on a portogram were significantly correlated with the depth of PV wall invasion. Patients presenting with both factors simultaneously had poor survival.
CONCLUSIONS: The depth of PV wall invasion significantly alters survival after curative pancreatic resection combined with PV resection. However, occasional long-term survival could be observed after curative resection in patients with deep PV wall invasion.

Entities:  

Mesh:

Year:  2007        PMID: 17309969     DOI: 10.1001/archsurg.142.2.172

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  33 in total

1.  Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis.

Authors:  Yanming Zhou; Zhiming Zhang; Yujian Liu; Bin Li; Donghui Xu
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

2.  Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma.

Authors:  Kwang Yeol Paik; Seong Ho Choi; Jin Seok Heo; Dong Wook Choi
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

3.  Extended pancreatic resections and lymphadenectomy: An appraisal of the current evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2010-02-27

Review 4.  Borderline resectable pancreatic cancer.

Authors:  Bhargava Mullapudi; Patrick J Hawkes; Asish Patel; Chandrakanth Are; Subhasis Misra
Journal:  Indian J Surg Oncol       Date:  2015-01-04

Review 5.  [R1 resection for pancreatic carcinoma].

Authors:  G F Weber; S Kersting; F Haller; R Grützmann
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

6.  Neoadjuvant therapy for pancreatic ductal adenocarcinoma-real effects or patient selection?

Authors:  Stefan Heinrich
Journal:  Hepatobiliary Surg Nutr       Date:  2018-08       Impact factor: 7.293

Review 7.  Management of borderline resectable pancreatic cancer.

Authors:  Amit Mahipal; Jessica Frakes; Sarah Hoffe; Richard Kim
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

8.  "Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of borderline resectable disease": a commentary on the article published by Kelly et al. In the Journal of Gastrointestinal Surgery 17:1209 (2013).

Authors:  Sanjay S Reddy; John P Hoffman
Journal:  J Gastrointest Surg       Date:  2014-02-25       Impact factor: 3.452

9.  A comprehensive assessment of transfusion in elective pancreatectomy: risk factors and complications.

Authors:  Raphael C Sun; Anna M Button; Brian J Smith; Richard F Leblond; James R Howe; James J Mezhir
Journal:  J Gastrointest Surg       Date:  2013-02-20       Impact factor: 3.452

10.  A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer.

Authors:  Olga Kantor; Mark S Talamonti; Susan J Stocker; Chi-Hsiung Wang; David J Winchester; David J Bentrem; Richard A Prinz; Marshall S Baker
Journal:  J Gastrointest Surg       Date:  2016-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.